Intelligent Bio Solutions Inc. revenue by segment INBS

Annual Quarterly

Intelligent Bio Solutions Inc. splits its revenue into 4 lines in its filings. The largest line in Q4 of fiscal 2026, the quarter ended Jun 30, 2026 was Sales Of Goods Cartidges at $624,971, 55% of the total.

USD in millions. The percent under a figure is the change from the same quarter a year earlier.

Line	Q4 FY2026 Jun 30, 2026	Q3 FY2026 Mar 31, 2026	Q2 FY2026 Dec 31, 2025	Q1 FY2026 Sep 30, 2025	Q4 FY2025 Jun 30, 2025	Q3 FY2025 Mar 31, 2025	Q2 FY2025 Dec 31, 2024	Q1 FY2025 Sep 30, 2024
Revenue	1	1	1	1	1	1	1	1
Sales Of Goods Cartidges	1 +29.3% share 54.5%	1 +59.2% share 66.3%	1 +33.1% share 57.6%	1 +42.8% share 57.6%	0 share 57.3%	0 share 60.6%	0 share 63.9%	0 share 51.4%
Other Sales Accessories	0 +72.2% share 25.4%	0 +80.0% share 20.5%	0 +35.7% share 14.9%	0 -2.8% share 16.6%	0 share 20.1%	0 share 16.6%	0 share 16.2%	0 share 21.8%
Sales Of Goods Readers	0 +19.9% share 20.0%	0 -15.9% share 13.1%	0 +104.1% share 27.5%	0 +22.7% share 25.8%	0 share 22.7%	0 share 22.7%	0 share 19.9%	0 share 26.8%
Biosensor Platform Technology	—	—	—	—	—	0 share 16.6%	—	—

How these figures are calculated

Quarterly columns are single-quarter amounts. When a 10-Q reports only a year-to-date total, as cash flow statements do, the quarter is that total minus the previous quarter's year-to-date total. The fourth quarter is the annual report's full year minus the first nine months. A column marked YTD is a year-to-date total, shown when the earlier report needed for the single quarter is missing. USD in millions. Each group is a separate split of total revenue, so the groups are not added together. Share of revenue is that line divided by total revenue. More on our methodology.

Company profile

Industry: Surgical & Medical Instruments & Apparatus (SIC 3841)
Listed as: INBS (Nasdaq)
Fiscal year ends: June 30
Incorporated in: DE
Headquarters: New York, NY
SEC filer status: Non-accelerated filer, Smaller reporting company
SEC CIK: 1725430
Former names: GBS Inc. (until Oct 18, 2022); Glucose Biosensor Systems (Greater China) Holdings, Inc. (until Sep 19, 2019)

Other Surgical & Medical Instruments & Apparatus companies

All 151 Surgical & Medical Instruments & Apparatus companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.